Literature DB >> 17265577

Improving comprehension for HIV vaccine trial information among adolescents at risk of HIV.

D A Murphy1, D Hoffman, G R Seage, M Belzer, J Xu, S J Durako, M Geiger.   

Abstract

A simplified version of the HIVNET prototype HIV vaccine process was developed for adolescents at risk of HIV by:(1) reducing reading level; (2) reorganizing; (3) adding illustrations; and (4) obtaining focus group feedback. Then adolescents (N = 187) in three cities were randomly assigned to the standard or simplified version. Adolescents receiving the simplified version had significantly higher comprehension scores (80% correct vs. 72% correct), with 37% of items significantly more likely to be answered correctly. They were also significantly more likely to recall study benefits and procedures. Overall, adolescents were less willing to participate in a potential HIV vaccine trial after presentation than prior to presentation. The present study indicates that it would be feasible for adolescents to participate in a vaccine trial, as simplification of vaccine information, combined with illustrations to depict key concepts, resulted in improved scores for adolescents on the comprehension and recall test.

Mesh:

Substances:

Year:  2007        PMID: 17265577     DOI: 10.1080/09540120600680882

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  15 in total

1.  Adolescent and Parent Perceptions about Participation in Biomedical Sexual Health Trials.

Authors:  Sara E Landers; Jenny K R Francis; Marilyn C Morris; Christine Mauro; Susan L Rosenthal
Journal:  Ethics Hum Res       Date:  2020-05

2.  Adolescents' understanding of research concepts: a focus group study.

Authors:  Diane R Blake; Celeste A Lemay; Margaret H Kearney; Kathleen M Mazor
Journal:  Arch Pediatr Adolesc Med       Date:  2011-06

3.  The effects of two health information texts on patient recognition memory: a randomized controlled trial.

Authors:  Erin Freed; Debra Long; Tonantzin Rodriguez; Peter Franks; Richard L Kravitz; Anthony Jerant
Journal:  Patient Educ Couns       Date:  2013-03-26

4.  A randomized trial of enhanced HIV risk-reduction and vaccine trial education interventions among HIV-negative, high-risk women who use noninjection drugs: the UNITY study.

Authors:  Beryl A Koblin; Sebastian Bonner; Donald R Hoover; Guozhen Xu; Debbie Lucy; Princess Fortin; Sara Putnam; Mary H Latka
Journal:  J Acquir Immune Defic Syndr       Date:  2010-03       Impact factor: 3.731

5.  Development and evaluation of a web-based assent for adolescents considering an HIV vaccine trial.

Authors:  Diane R Blake; Celeste A Lemay; Louise S Maranda; J Dennis Fortenberry; Margaret H Kearney; Kathleen M Mazor
Journal:  AIDS Care       Date:  2015-03-24

6.  Factors associated with willingness to participate in a pharmacologic addiction treatment clinical trial among people who use drugs.

Authors:  Sasha Uhlmann; Michael John Milloy; Keith Ahamad; Paul Nguyen; Thomas Kerr; Evan Wood; Lindsey Richardson
Journal:  Am J Addict       Date:  2015-03-24

7.  Comprehension of a simplified assent form in a vaccine trial for adolescents.

Authors:  Sonia Lee; Bill G Kapogiannis; Patricia M Flynn; Bret J Rudy; James Bethel; Sushma Ahmad; Diane Tucker; Sue Ellen Abdalian; Dannie Hoffman; Craig M Wilson; Coleen K Cunningham
Journal:  J Med Ethics       Date:  2013-01-24       Impact factor: 2.903

8.  Inclusion of South African adolescents in HIV vaccine trials.

Authors:  David H Adler
Journal:  J AIDS HIV Res       Date:  2012-02-01

9.  Using social networks to recruit an HIV vaccine preparedness cohort.

Authors:  Thomas W Valente; Jennifer B Zogg; Shawna Christensen; Jean Richardson; Andrea Kovacs; Eva Operskalski
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12-01       Impact factor: 3.731

10.  Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugs.

Authors:  Bethany White; Annie Madden; Margaret Hellard; Thomas Kerr; Maria Prins; Kimberly Page; Gregory J Dore; Lisa Maher
Journal:  Drug Alcohol Rev       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.